Literature DB >> 22324172

Pityriasis rubra pilaris: evolution of challenges in promising treatment options.

Virendra N Sehgal1, Govind Srivastava, Prashant Verma.   

Abstract

Pityriasis rubra pilaris is an uncommon inflammatory dermatosis that is well recognized across the globe. Erythroderma is a common presentation. A precise diagnosis of pityriasis rubra pilaris is based on morphologic features and is classified into 6 types: classic adult onset (type I), atypical adult (type II), classic juvenile (type III), circumscribed juvenile (type IV), atypical juvenile (type V), and human immunodeficiency virus-associated (type VI). Several conventional systemic and/or topical treatments are currently in use. Largely, their results are unsatisfactory and limited by long-term toxicity. The authors investigate the efficacy of a wide spectrum of drugs by examining historical (archive) and promising (modern) treatment modalities for the treatment of pityriasis rubra pilaris.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22324172

Source DB:  PubMed          Journal:  Skinmed        ISSN: 1540-9740


  1 in total

1.  Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris.

Authors:  Alessandro Di Stefani; Marco Galluzzo; Marina Talamonti; Andrea Chiricozzi; Antonio Costanzo; Sergio Chimenti
Journal:  J Dermatol Case Rep       Date:  2013-03-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.